Hemostasis system in patients with schizophrenia and schizophrenia spectrum disorders was examined using “Fibrinodynamics” technology that allows evaluating the overal coagulation, fibrinolysis, and hemostasis potentials. All indices, except for the parameter characterizing the hemostasis balance, were statistically higher (p<0.0001) in patients than in healthy volunteers (control). In most patients, the hemostasis system remained balanced despite changes in individual coagulation and fibrinolysis parameters. The obtained results have a fundamental importance, expand the understanding of the pathogenesis of endogenous mental disorders, and are useful for the development of personalized approaches to the treatment of these patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rupprecht R, Rupprecht C, Di Benedetto B, Rammes G. Neuroinflammation and psychiatric disorders: Relevance of C1q, translocator protein (18 kDa) (TSPO), and neurosteroids. World J. Biol. Psychiatry. 2022;23(4):257-263. https://doi.org/10.1080/15622975.2021.1961503
Buckley PF. Neuroinflammation and schizophrenia. Curr. Psychiatry Rep. 2019;21(8):72. https://doi.org/10.1007/s11920-019-1050-z
Troubat R, Barone P, Leman S, Desmidt T, Cressant A, Atanasova B, Brizard B, El Hage W, Surget A, Belzung C, Camus V. Neuroinflammation and depression: A review. Eur. J. Neurosci. 2021;53(1):151-171. https://doi.org/10.1111/ejn.14720
Müller N. Inflammation in schizophrenia: pathogenetic aspects and therapeutic considerations. Schizophr. Bull. 2018;44(5):973-982. https://doi.org/10.1093/schbul/sby024
Khamisy-Farah R, Fund E, Raibman-Spector S, Adawi M. Inflammatory markers in the diagnosis of fibromyalgia. Isr. Med. Assoc. J. 2021;23(12):801-804.
Gille B, De Schaepdryver M, Dedeene L, Goossens J, Claeys KG, Van Den Bosch L, Tournoy J, Van Damme P, Poesen K. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis? J. Neurol. Neurosurg. Psychiatry. 2019;90(12):1338-1346. https://doi.org/10.1136/jnnp-2018-319586
Medications that Affect Hemostasis, in Diagrams and Tables. Voronezh, 2019.
Saraeva NO. Hematology. Irkutsk, 2015. Russian.
Lalic-Cosic S, Dopsaj V, Kovac M, Pruner I, Littmann K, Mandic-Markovic V, Mikovic Z, Antovic A. Evaluation of global haemostatic assays and fibrin structure in patients with pre-eclampsia. Int. J. Lab. Hematol. 2020;42(3):322-330. https://doi.org/10.1111/ijlh.13183
Brusov OS, Matveev IA, Kirillov PS, Faktor MI, Karpova NS, Vasilyeva EF, Katasonov AB, Zozulya SA, Klushnik TP. Risk assessment of thrombotic events in patients with schizophrenia and schizoaffective disorder in the acute state: the “Fibrinodynamics” technology. Zh. Nevrol. Psikhiatr. 2017;117(11):91-100. Russian. https://doi.org/10.17116/jnevro201711711191-100
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 176, No. 9, pp. 375-379, September, 2023
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Karpova, N.S., Brusov, O.S., Oleichik, I.V. et al. Hemostasis System in Patients with Schizophrenia and Schizophrenia Spectrum Disorders. Bull Exp Biol Med 176, 390–393 (2024). https://doi.org/10.1007/s10517-024-06030-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-024-06030-1